Agios Pharm
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $12,455 | $8,726 | $10,730 | $8,964 |
Gross Profit | 9,494 | 7,641 | 9,470 | 8,181 |
EBITDA | -110,761 | -105,351 | -123,670 | -102,811 |
EBIT | -112,020 | -106,629 | -125,037 | -104,156 |
Net Income | -112,020 | -89,289 | -96,523 | 947,915 |
Net Change In Cash | 12,455 | 8,726 | 10,730 | 8,964 |
Free Cash Flow | -77,999 | -112,255 | -134,134 | -84,637 |
Cash | 80,871 | 78,964 | 76,247 | 253,730 |
Basic Shares | 57,932 | 57,459 | 57,156 | 58,433 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $36,498 | $26,823 | $14,240 | $41 |
Gross Profit | 32,333 | 17,319 | 12,536 | -18,777 |
EBITDA | -425,737 | -384,864 | -380,483 | -337,733 |
EBIT | -431,390 | -391,487 | -399,042 | -356,510 |
Net Income | 673,725 | -352,088 | -74,555 | 1,604,715 |
Net Change In Cash | 36,498 | 26,823 | 14,240 | 41 |
Cost of Revenue | -63,867 | 75,690 | ||
Free Cash Flow | -391,526 | -297,061 | -314,359 | -413,061 |
Cash | 76,247 | 88,205 | 139,259 | 203,126 |
Basic Shares | 57,889 | 55,651 | 54,789 | 60,447 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.93 |
2025-03-31 | -$1.55 |
2024-12-31 | -$1.74 |
